Accueil › Cancer de la prostate › Pennsylvanie › Philadelphia
Essais cliniques pour Cancer de la prostate à Philadelphia, PA
44 études pour Cancer de la prostate recherchent des participants dans et autour de Philadelphia (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Recrutement en coursPhase 1/2
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Recrutement en coursPhase 3
- Thomas Jefferson University Hospital, Philadelphia
- Jefferson Torresdale Hospital, Philadelphia
- Asplundh Cancer Pavilion, Willow Grove · à 13 mi
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Recrutement en coursÉtude observationnelleVolontaires sains bienvenus
- Reading Hospital McGlinn Cancer Institute at Phoenixville, Phoenixville · à 22 mi
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
Recrutement en coursPhase 1
- Sidney Kimmel Cancer Center - Jefferson Health, Philadelphia
DESTINY-PANTUMOUR04
Recrutement en coursÉtude observationnelle
- Research Site, Philadelphia
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Recrutement en coursPhase 3
- Fox Chase Cancer Center ( Site 0076), Philadelphia
- MidLantic urology ( Site 0022), Bala-Cynwyd · à 5 mi
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Recrutement en coursPhase 3
- MidLantic urology, Bala-Cynwyd · à 5 mi
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Recrutement en coursPhase 2/3
- Fox Chase Cancer Center, Philadelphia
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
Recrutement en coursPhase 2
- Philadelphia MultiService Center, Philadelphia, PA, Philadelphia
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Recrutement en coursPhase 3
- Perelman Center for Advanced Medicine ( Site 0067), Philadelphia
- Abramson Cancer Center - Penn Medicine ( Site 0079), Philadelphia
First-Time-in-Human Study of GSK5471713 in Adults With mCRPC
Recrutement en coursPhase 1/2
- GSK Investigational Site, Philadelphia
Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer
Recrutement en coursPhase 1
- Thomas Jefferson University, Philadelphia
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
Recrutement en cours
- MidLantic Urology, Bala-Cynwyd · à 5 mi
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Recrutement en coursPhase 3
- Christiana Care Health System-Concord Health Center, Chadds Ford · à 23 mi
- Christiana Care Health System-Wilmington Hospital, Wilmington · à 25 mi
A Study of Tarlatamab for People With Prostate Cancer
Recrutement en coursPhase 2
- Thomas Jefferson University Hospital, Philadelphia
A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
Recrutement en coursPhase 2
- Abramson Cancer Center of the University of Pennsylvania, Hospital of the University of Pennsylvania, Philadelphia
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
Recrutement en coursPhase 1
- Thomas Jefferson University, Philadelphia
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Recrutement en coursPhase 3
- Penn Presbyterian Medical Center, Philadelphia
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
- Thomas Jefferson University Hospital, Philadelphia
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Recrutement en coursPhase 1/2
- University of Pennsylvania, Perelman School of Medicine, Philadelphia
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
Recrutement en coursPhase 1
- Thomas Jefferson University Honickman Center, Philadelphia
Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer
Recrutement en coursPhase 1
- Thomas Jefferson University, Philadelphia
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
Recrutement en coursPhase 1
- Investigative Site #109, Philadelphia
PSMA PET Combined With MRI for the Detection of PCa
Recrutement en coursPhase 3Volontaires sains bienvenus
- MidLantic Urology, Philadelphia
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Recrutement en coursPhase 3
- Philadelphia Veterans Administration Medical Center, Philadelphia
- Christiana Care Health System-Concord Health Center, Chadds Ford · à 23 mi
- Christiana Care Health System-Wilmington Hospital, Wilmington · à 25 mi
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
Recrutement en coursPhase 1
- MidLantic Urology, Bala-Cynwyd · à 5 mi
Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
Recrutement en coursPhase 1
- Thomas Jefferson University, Philadelphia
A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
Recrutement en coursPhase 1/2
- Thomas Jefferson University Hospital, Philadelphia
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
Recrutement en coursPhase 2
- Corporal Michael J. Crescenz VA Medical Center, Philadelphia
TERPS Trial for de Novo Oligometastic Prostate Cancer
Recrutement en coursPhase 2
- Sidney Kimmel Cancer Center at Jefferson Health, Philadelphia
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
Recrutement en coursÉtude observationnelle
- Fox Chase Cancer Center - Temple Health, Philadelphia
Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study
Recrutement en coursÉtude observationnelleVolontaires sains bienvenus
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
Extending Prostate Genetic Awareness, Navigation, and Delivery: The EXPAND Network
Recrutement en coursÉtude observationnelleVolontaires sains bienvenus
- Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
Peer Navigation for the Support of Metastatic Prostate Cancer Patients Undergoing Genetic Evaluation
Recrutement en cours
- Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University, Philadelphia
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
Recrutement en coursPhase 2/3
- Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, Philadelphia
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Recrutement en coursPhase 1/2
- Thomas Jefferson University, Sidney Kimmel Comprehensive Cancer Center, Philadelphia
Study of AZD0754 in Participants With Metastatic Prostate Cancer
Recrutement en coursPhase 1/2
- Research Site, Philadelphia
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Recrutement en coursPhase 1
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
- Fox Chase Cancer Center, Philadelphia
Hypofractionated WPPT With HDR Boost
Recrutement en coursPhase 2
- University of Pennsylvania, Philadelphia
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
Recrutement en coursPhase 1
- MidLantic Urology, Bala-Cynwyd · à 5 mi
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
Recrutement en coursPhase 3
- Christiana Care Health System-Concord Health Center, Chadds Ford · à 23 mi
- Christiana Care Health System-Wilmington Hospital, Wilmington · à 25 mi
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
Recrutement en coursPhase 4
- Albert Einstein Healthcare Network, Philadelphia
Prostate Tissue BioBank
Recrutement en coursÉtude observationnelle
- University of Pennsylvania, Philadelphia
Adaptive Radiation Therapy for Men With Intermediate- or High-Risk Prostate Cancer
Recrutement en cours
- Fox Chase Cancer Center, Philadelphia
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Recrutement en coursÉtude observationnelle
- Massive Bio SYNERGY-AI site, Philadelphia
Essais pour Cancer de la prostate dans d'autres villes
- New York City, NY103 études
- Houston, TX76 études
- Los Angeles, CA61 études
- Boston, MA59 études
- St. Louis, MO46 études
- Chicago, IL45 études
- San Francisco, CA45 études
- Baltimore, MD43 études
- Nashville, TN42 études
- Seattle, WA42 études
- Washington, DC38 études
- Dallas, TX36 études
Autres études à Philadelphia
- Cancer (tous types)59 études
- Cancer du sein56 études
- Cancer du poumon non à petites cellules51 études
- Cancer métastatique46 études
- Cancer colorectal44 études
- Cancer de l'ovaire44 études
- Cancer du poumon36 études
- Leucémie aiguë myéloïde34 études
- Insuffisance cardiaque31 études
- Cancer de l'endomètre28 études
- Dépression26 études
- Carcinome épidermoïde de la tête et du cou26 études
Source : ClinicalTrials.gov, données récupérées le 5 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.